Research Topics
Genomes and Genes | M HebbarSummaryAffiliation: CHRU de Lille Country: France Publications
| Collaborators
|
Detail Information
Publications
Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patientsM Hebbar
Laboratoire d Oncologie Moléculaire Humaine, Centre Oscar Lambret, Lille, France
Int J Biol Markers 18:116-22. 2003..The aim of this study was to assess the prognostic value of tumoral sialyltransferase expression and of circulating soluble E-selectin (sE-selectin) in node-negative breast cancer patients...
Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study)Mohamed Hebbar
Unité d Oncologie Médicale, Hôpital Huriez CHRU, Lille, France
Cancer Invest 24:154-9. 2006..1 percent). Median progression-free and overall survivals were 8.8 and 18.7 months, respectively. Only 2 patients (5.1 percent) had Grade 3 oxaliplatin-related sensory-neuropathy. This schedule had so promising efficacy and safety...
Significance of soluble endothelial molecule E-selectin in patients with breast cancerM Hebbar
Laboratory of Human Molecular Oncology, Centre Oscar Lambret, Lille, France
Int J Biol Markers 15:15-21. 2000..5 years), multivariate analyses demonstrated a prognostic value of sE-selectin and tumor size. This study suggests that endothelial activation might play a role in the development of BC. This role seems not to be related to angiogenesis...
Phase II trial of docetaxel therapy in patients with advanced hepatocellular carcinomaMohamed Hebbar
Unité d Oncologie Médicale, Centre Hospitalo Universitaire, Lille, France
Oncology 70:154-8. 2006..We assessed the safety and efficacy of docetaxel, a microtubule inhibitor, in patients with advanced hepatocellular carcinoma (HCC)...
Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancerMohamed Hebbar
Department of Medical Oncology, Universitary Hospital, Lille, France
Anticancer Drugs 17:855-7. 2006..These results provide further evidence for the lack of usefulness of epidermal growth factor receptor detection by immunohistochemistry for cetuximab therapy in patients with metastatic colorectal cancer...
Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosisM Hebbar
Service de Medecine Interne, Hopital Claude Huriez, Lille, France
Clin Exp Immunol 136:388-92. 2004..These results suggest that soluble CD28 could play an important role in the regulation of autoimmune diseases...
Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancerMohamed Hebbar
Medical Oncology Unit, University Hospital, Lille, France
Oncology 73:185-91. 2007..To identify easily available predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer...
Current place of high-dose irinotecan chemotherapy in patients with metastatic colorectal cancerMohamed Hebbar
Unité d Oncologie Médicale, Centre Hospitalo Universitaire, 1 rue Michel Polonovski, Lille 59037, France
J Cancer Res Clin Oncol 135:749-52. 2009..It was initially administered as monotherapy, but is now generally used in combination with 5-fluorouracil or targeted therapies (cetuximab or bevacizumab), with various doses...
E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancerMohamed Hebbar
Department of Medical Oncology, University Hospital, Lille, France
Eur J Cancer 45:1871-6. 2009..This polymorphism detection may permit better selection of patients suitable for adjuvant therapy, especially among those with stage II disease...
KRAS mutational status assessment in patients with metastatic colorectal cancer: are the clinical implications so clear?M Hebbar
Department of Medical Oncology, University Hospital, Lille, France
Eur J Cancer Care (Engl) 19:167-71. 2010..of objective response constantly observed in retrospective analyses in patients with a tumour presenting a KRAS mutation definitively exclude these patients while stable disease (and potentially a slight gain in survival) may be obtained?..
Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancerMohamed Hebbar
Department of Medical Oncology, University Hospital, Lille, France
Cancer Treat Rev 35:668-75. 2009..Ongoing and planned trials will assess the addition of anti-angiogenic and anti-epidermal growth factor receptor agents to chemotherapy regimens...
[Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients]D Launay
Service de Medecine Interne, Hopital Claude Huriez CHRU, 59037 Lille, France
Rev Med Interne 22:819-29. 2001..A good knowledge of the clinical, biological and functional features of pulmonary hypertension in systemic sclerosis is therefore necessary to suspect and to diagnose pulmonary hypertension as early as possible...
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR studyT Andre
Hopital Tenon, Department of Medical Oncology, Paris, France
Ann Oncol 18:77-81. 2007..Celecoxib is an anti-cyclooxygenase-2 drug with anti-neoplastic properties. In the present study, celecoxib was evaluated in combination with FOLFOX7 regimen and as a single agent in maintenance therapy...
Relationship between parity and clinical and biological features in patients with systemic sclerosisD Launay
, H pital Claude Huriez, CHRU, Lille, France
J Rheumatol 28:509-13. 2001..6 vs 25.4 +/- 13.4 yrs; p < 0.05). CONCLUSION: Pregnancy related microchimerism could be preferentially associated with limited SSc and pulmonary fibrosis. Microchimerism may be facilitated in cases in which the fetus is female...
FOLFIRI chemotherapy in patients with advanced non resectable esophageal or junctional adenocarcinoma: a pilot studyC Ferte
Department of Medical Oncology, University Hospital, Lille, France
J Chemother 23:358-61. 2011..To conclude, FOLFIRI regimen appears quite active, with an acceptable safety profile in patients with advanced esophageal or junctional adenocarcinoma...
Aerosolized iloprost in CREST syndrome related pulmonary hypertensionD Launay
Department of Internal Medicine, Functional Cardiac Exploration, Regional University Hospital, Lille, France
J Rheumatol 28:2252-6. 2001..However, patients who could benefit from this treatment will probably have to undergo careful criteria selection...
Docetaxel therapy for advanced hepatocellular carcinoma developed in healthy liver: report of three casesO Romano
Department of Medical Oncology, University Hospital, Lille, France
J Chemother 20:518-20. 2008..These results suggest that chemotherapy, and especially docetaxel, could be safe and effective in patients with HCC developed in healthy liver, and should be assessed in specific trials...
[Wegener's granulomatosis in the elderly patient]A L Fauchais
Service de Medecine Interne, Hopital Claude Huriez, CHRU, Place de Verdun, 59037 Lille, France
Rev Med Interne 22:127-31. 2001..To determine aged-related variations in clinical and biological presentation and outcome in Wegener's granulomatosis...
Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancerPhilippe Zerbib
Inserm ERI 9, Faculté de Médecine Lille, France Université de Lille 2, EA2693, Lille, France
J Surg Res 153:239-45. 2009..We thus hypothesized that inhibition of the TF pathway by active site-blocked FVIIa (FFR-FVIIa) may prevent the development of hepatic metastasis in CRC...
Expression of nerve growth factor receptors and their prognostic value in human breast cancerS Descamps
, Centre Oscar Lambret, 59020 Lille, France
Cancer Res 61:4337-40. 2001..In Cox multivariate analyses, TrkA was not a prognostic parameter. This study demonstrates the expression of NGFRs in breast cancer and points out that patients with high levels of TrkA have a more favorable overall survival prognosis...
[Psychiatric complications of corticoid therapy in the elderly over 65 years of age treated for Horton disease]A L Fauchais
Service de Medecine Interne A, Hopital Claude Huriez, CHRU, 59037 Lille, France
Rev Med Interne 23:828-33. 2002..To analyse steroid psychiatric related complications in aged (> 65 years old) with temporal arteritis (TA)...
[Systemic sclerosis and pregnancy]D Launay
Service de Medecine Interne, Hopital Claude Huriez, CHRU Lille, Rue Michel Polonovski, 59037 Lille, France
Rev Med Interne 23:607-21. 2002..Finally, it has been recently suggested that pregnancies could be involved in the pathogenesis of SSc through persisting microchimerism of fetal origin...
Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastasesS Truant
Department of Digestive and Transplantation Surgery, University Hospital, Hospital Huriez, 59037 Lille Cedex, France
Br J Surg 92:362-9. 2005..However, additional information provided by PET is not as reliable as suggested by earlier retrospective studies...
O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanomaNicolas Penel
Département de Cancérologie Générale, Centre Oscar Lambret, 59020, Lille, France
Invest New Drugs 26:561-5. 2008..Nowadays, there is no consensual and effective treatment in metastatic uveal melanoma (MUM). Numerous preclinical data (for example, 75% of MUM express c-kit) suggest that imatinib mesylate (IM) may be a potential treatment of UMM...
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in peripheral blood mononuclear cells in systemic sclerosisDavid Launay
Department of Internal Medicine, Regional University Hospital-Claude Huriez, Lille, France
J Rheumatol 31:88-95. 2004..Binding between PBMC surface Sialyl-LewisX and activated endothelial cell E-selectin might therefore play a role in the pathogenesis of SSc-related isolated pulmonary hypertension...
[Targeting the epidermal growth factor receptor in colorectal cancer: clinical results]Antoine Adenis
Département de Cancérologie Digestive et Urologique, Centre Oscar Lambret, BP 307, 59020 Lille Cedex
Bull Cancer 92:S21-8. 2005..At this point of the clinical development of these all EGFR inhibitors (monoclonal antibodies or tyrosine kinase inhibitors) in MCRC, informative data from randomized studies are urgently needed...
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 studyAmani Asnacios
Department of Hepato gastro enterology, Pitie Salpetriere Hospital, Paris, France
Cancer 112:2733-9. 2008....
Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II studyJulien Taieb
Service d Hepatogastroenterologie, Groupe Hospitalier Pitie Salpetriere, 47 83 boulevard de l Hopital, 75013 Paris, France
J Clin Oncol 23:502-9. 2005..To evaluate the efficacy and tolerability of the metastatic irinotecan plus oxaliplatin (MIROX) strategy (adjuvant FOLFOX-7 followed by FOLFIRI), in patients with resectable metastatic colorectal cancer...
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin levelValerie Boige
Gastrointestinal Oncology Unit, Department of Medicine, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
Eur J Cancer 42:456-9. 2006..51 and 3 ULN. However, the antitumour activity of single agent CPT-11 was not significant in advanced HCC...
Association between systemic sclerosis and breast cancer: eight new cases and review of the literatureDavid Launay
, CHRU, , 1 Place Verdun, 59037 Lille, France
Clin Rheumatol 23:516-22. 2004..SSc is probably not a paraneoplastic disease since the anticancer treatment has no influence on the evolution of SSc. However, it can be suggested that SSc could be a disease facilitating breast cancer and/or metastases development...
